Michael Mensinger
Fortune : 2 M $ au 31/05/2026
Fortune : 2 M $ au 31/05/2026
Mr. Michael R.
Mensinger is a Chief Product Officer at Beta Bionics, Inc. Mr. Mensinger was previously employed as a Chief Technology Officer by Companion Medical, Inc. and an Engineering Manager by DexCom, Inc. He received his undergraduate degree from the University of Delaware.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BETA BIONICS, INC. 0,41 % | 02/06/2026 | 184 415 ( 0,41 % ) | 2 M $ | 31/05/2026 |
BETA BIONICS, INC. -.--% | 29/01/2025 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| BETA BIONICS, INC. | Corporate Officer/Principal | 01/08/2023 |
| Sociétés | Poste | Fin |
|---|---|---|
Companion Medical, Inc.
Companion Medical, Inc. Medical SpecialtiesHealth Technology Manufactures insulin injector pens for diabetes management | Directeur Technique/Scientifique/R&D | 01/08/2023 |
| DEXCOM, INC. | Corporate Officer/Principal | 01/04/2017 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Companion Medical, Inc.
Companion Medical, Inc. Medical SpecialtiesHealth Technology Manufactures insulin injector pens for diabetes management | Health Technology |
DexCom, Inc.
DexCom, Inc. Medical SpecialtiesHealth Technology Designs, develops and commercializes continuous glucose monitoring systems for management of diabetes & metabolic health by patients, caregivers and clinicians | Health Technology |
University of Delaware
University of Delaware Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Beta Bionics, Inc.
Beta Bionics, Inc. Medical SpecialtiesHealth Technology Designs, develops, manufactures and markets medical devices for diabetes disease | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national